TEAM.NASDAQAtlassian CORP

Form 4: Atlassian CEO Michael Cannon-Brookes Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4


Atlassian's CEO, Michael Cannon-Brookes, executed multiple sales of Class A Common Stock on October 21, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • Michael Cannon-Brookes, CEO and Co-Founder of Atlassian, reported the sale of Class A Common Stock on October 21, 2024.
  • The sales were executed under a Rule 10b5-1 trading plan adopted on February 8, 2024.
  • The transactions involved multiple trades at varying prices, with weighted-average prices reported for each set of transactions.
  • The sales were conducted at prices ranging from $189.83 to $193.46 per share.
  • Following the reported transactions, Cannon-Brookes continues to beneficially own a significant amount of Class A Common Stock indirectly through a trust.

Sentiment

Score: 5

Explanation: The document is neutral as it reports routine stock sales under a pre-existing trading plan. There is no indication of positive or negative sentiment.

Risks

  • The continued execution of sales under the 10b5-1 plan could exert downward pressure on the stock price.
  • Investor sentiment may be affected by insider selling activity, even if pre-planned.

Future Outlook

The document does not contain any specific forward-looking statements, but further sales may occur under the existing 10b5-1 trading plan.

Industry Context

Insider transactions are common and closely watched in the tech industry. Sales by executives can sometimes be interpreted negatively by investors, even when conducted under pre-arranged plans.

Stakeholder Impact

  • Shareholders may react to the news of insider selling, although the existence of a 10b5-1 plan mitigates potential negative interpretations.
  • The impact on employees, customers, suppliers, and creditors is likely to be minimal.

Key Dates

DateDescription
2024-02-08Date the Reporting Person adopted the Rule 10b5-1 trading plan
2024-10-21Date of the reported transactions (stock sales)
2024-10-22Date of the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.